Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will report its third quarter 2022 financial results after... | October 18, 2022
Zymeworks Inc. (ZYME) is priced at $5.52 after the most recent trading session. At the very opening of the session, the stock price was $4.88 and reached a high price of $5.65, prior to closing the session it reached the value of $4.89. The stock touched a low price of $4.88.Recently in News on Octo
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday. The Dow traded down 0.74% to ...
Zymeworks Inc. (“Zymeworks” or the “Company”) (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, is pleased to announce that the Company’s securityholders have approved its p...
03.10.2022 - Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in upcoming investor conferences: Stifel 2022 Healthcare Conference. ...